Global Blood Pressure Monitoring Devices Market By Product Type (Digital Blood Pressure Monitor, Sphygmomanometer, Transducers, Others) By Technology (Digital, Android, Wearable) By End User (Hospitals & Clinics, Ambulatory Surgery Centres, Home Care, Others) By Region, Competition Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.82 Billion
CAGR (2026-2031)	7.49%
Fastest Growing Segment	Digital Blood Pressure Monitor
Largest Market	Asia Pacific
Market Size (2031)	USD 4.35 Billion

Market Overview

The Global Blood Pressure Monitoring Devices Market will grow from USD 2.82 Billion in 2025 to USD 4.35 Billion by 2031 at a 7.49% CAGR. Blood pressure monitoring devices are diagnostic instruments designed to measure arterial pressure, encompassing manual sphygmomanometers and automated digital systems for professional and personal use. The market is fundamentally supported by the escalating global prevalence of chronic cardiovascular conditions and a rapidly aging population that necessitates frequent health assessment to prevent acute medical events. According to the World Health Organization, in 2024, an estimated 1.4 billion adults aged 30 to 79 years worldwide lived with hypertension, highlighting the critical demand for effective detection tools.

A significant challenge that could impede market expansion involves the accuracy variances found in automated monitors used outside controlled clinical environments. Inconsistent readings compared to professional standards can lead to incorrect diagnoses and erode trust among healthcare providers regarding patient personal monitoring data. Furthermore, navigating complex regulatory approval processes and stringent validation standards across different international jurisdictions creates substantial barriers to entry and delays the distribution of affordable monitoring solutions.

Key Market Drivers

The rising global prevalence of hypertension and cardiovascular diseases stands as a primary catalyst propelling the blood pressure monitoring devices market. This surge is intricately linked to lifestyle-related risk factors such as obesity and sedentary behavior, which are intensifying the demand for accurate diagnostic tools across both clinical and home settings. As the burden of chronic conditions grows, healthcare systems are prioritizing early detection and consistent management to mitigate severe outcomes like stroke and heart failure. According to the American Heart Association, January 2024, in the 'Heart Disease and Stroke Statistics—2024 Update', approximately 122.4 million adults in the United States had high blood pressure, underscoring the critical need for widely accessible monitoring solutions to address this expanding patient pool.

Simultaneously, the expansion of remote patient monitoring (RPM) and telehealth infrastructure is reshaping market dynamics by transitioning care from hospitals to personal environments. This driver is supported by the integration of wireless data transmission in monitoring devices, enabling physicians to track patient vitals in real-time and adjust treatments proactively. The adoption of these digital health tools has become a structural component of modern medical practice rather than a temporary trend. According to the American Medical Association, January 2024, in the '2024 Digital Health Study', 20.3 percent of physicians reported using remote patient monitoring tools in their practices, twice the rate observed in 2018. This shift toward connected care is reflected in the volume of devices being distributed globally; for instance, according to Omron Corporation, September 2024, in the 'Integrated Report 2024', the company recorded global sales of 22.46 million blood pressure monitors for the fiscal year 2023.

Download Free Sample Report

Key Market Challenges

Accuracy variances found in automated monitors used outside controlled clinical environments constitute a primary obstacle to the expansion of the blood pressure monitoring devices market. When personal monitoring devices produce inconsistent readings compared to professional references, it creates significant hesitation among healthcare practitioners to rely on patient-generated data for diagnostic decisions. This skepticism directly reduces the willingness of medical professionals to prescribe or recommend home monitoring solutions, stifling the broader adoption of these technologies.

According to the American Medical Association, in 2024, approximately 80 percent of blood pressure devices sold through top e-commerce sites in the United States had not been clinically validated for accuracy. Such high rates of non-validation undermine consumer confidence and create a fractured market environment where reliable, certified manufacturers struggle to compete against lower-quality alternatives. Consequently, the inability to guarantee consistent measurement precision across all retail products limits the market's potential to fully integrate into standard chronic disease management protocols and impedes revenue growth for compliant manufacturers.

Key Market Trends

The emergence of cuffless wearable bio-sensing technologies is revolutionizing the market by enabling continuous, non-invasive blood pressure tracking without the discomfort of traditional inflatable cuffs. These devices utilize optical sensors and proprietary algorithms to measure signals from the wrist or finger, providing 24/7 data that captures nocturnal dips and variability often missed by sporadic spot-checks. This shift addresses the critical issue of patient compliance, as the passive nature of the technology encourages sustained usage and generates longitudinal data sets for more accurate hypertension management. According to Fitt Insider, May 2025, in the article 'Aktiia Scores $42M for Next-Gen Blood Pressure Tech', the Swiss manufacturer Hilo (formerly Aktiia) has successfully sold over 120,000 cuffless monitoring devices across 40 countries, validating the growing commercial viability and consumer demand for these optical measurement solutions.

The integration of artificial intelligence for predictive hypertension analytics is transforming devices from simple measurement tools into comprehensive cardiovascular risk assessment platforms. Manufacturers are embedding machine learning algorithms directly into monitoring systems to analyze pressure pulse waves for irregularities, allowing for the early detection of comorbidities such as atrial fibrillation alongside standard blood pressure readings. This technological advancement empowers patients and physicians with actionable insights, facilitating proactive interventions before acute cardiac events occur. According to OMRON Healthcare, May 2025, in the press release 'OMRON Healthcare Evolves the Blood Pressuring Experience with AI-powered AFib detection', their new monitors featuring the IntelliSense AI algorithm demonstrated a 95 percent sensitivity and 98 percent specificity for detecting atrial fibrillation in clinical studies, establishing a new standard for home-based diagnostic accuracy.

Segmental Insights

The Digital Blood Pressure Monitor segment represents the fastest-growing category in the Global Blood Pressure Monitoring Devices Market, driven by a fundamental shift toward home-based healthcare. Patients are increasingly adopting these devices due to their ease of operation and ability to integrate with telehealth systems for remote data sharing. This trend is significantly reinforced by clinical guidelines from institutions such as the American Heart Association, which advocate for self-measured monitoring to ensure better hypertension control. Consequently, the demand for reliable, automated digital monitors continues to rise among proactive consumers and healthcare providers.

Regional Insights

Asia Pacific stands as the leading region in the Global Blood Pressure Monitoring Devices Market, primarily driven by its massive patient pool and rapidly aging population. The region dominates the global landscape due to the escalating prevalence of lifestyle-induced hypertension in densely populated nations like China and India. This growth is further accelerated by favorable government initiatives, such as the streamlined device approval pathways implemented by China’s National Medical Products Administration, which encourage innovation and accessibility. Additionally, rising healthcare expenditure and a strong cultural shift toward preventive home healthcare reinforce Asia Pacific's commanding market position.

Recent Developments

• In December 2024, Withings received FDA clearance for the BPM Pro 2, a next-generation cellular blood pressure monitor designed to enhance remote patient monitoring. The device was engineered to assist healthcare providers in managing chronic conditions such as hypertension by transmitting data securely via cellular networks, eliminating the need for Wi-Fi or smartphone pairing. The monitor featured a unique patient engagement tool that allowed care teams to display customizable questions on the device's digital screen. This innovation aimed to improve patient adherence and provide clinicians with reliable, real-time health insights for more effective treatment adjustments.
• In November 2024, Omron Healthcare secured De Novo authorization from the U.S. Food and Drug Administration for its latest home blood pressure monitors featuring AI-powered atrial fibrillation detection. This regulatory approval recognized the company's novel machine learning algorithm, which analyzes pressure pulse waves during routine blood pressure checks to identify irregular heart rhythms. The technology was developed to screen for atrial fibrillation with high accuracy, addressing a critical risk factor for stroke. This development represented a significant breakthrough in preventive cardiac care, enabling users to detect potential heart issues using standard home monitoring equipment.
• In September 2024, Huawei launched the Watch D2, a smartwatch equipped with ambulatory blood pressure monitoring capabilities, during a global product event. The device featured an integrated mechanical airbag and a micro-pump system, allowing it to provide precise measurements similar to traditional cuff-based instruments. Certified by regulatory bodies in Europe and China, the watch was designed to track blood pressure continuously over a 24-hour period, including during sleep. This launch underscored the company's commitment to integrating medical-grade health monitoring into consumer wearables, offering users a convenient solution for managing hypertension and tracking cardiovascular health.
• In July 2024, Aktiia entered into a strategic collaboration with Lindus Health to execute a comprehensive clinical trial for its optical blood pressure monitoring bracelet. The partnership focused on evaluating the user experience and clinical utility of Aktiia’s cuffless technology among a large cohort of participants with diagnosed hypertension. By utilizing Lindus Health’s advanced digital trial platform, the companies aimed to gather extensive data on continuous blood pressure patterns and the impact of non-invasive monitoring on disease management. This initiative highlighted the growing industry focus on validating continuous monitoring technologies to replace intermittent cuff readings.

Key Market Players

• Omron Corporation
• A&D Medical Inc.
• Philips Healthcare
• Hillrom, Inc.
• General Electric Company
• Panasonic Corporation
• Microlife Corporation
• Beurer GmbH
• SunTech Medical, Inc.
• iHealth Labs, Inc.

By Product Type	By Technology	By End User	By Region
Digital Blood Pressure Monitor Sphygmomanometer Transducers Others	Digital Android Wearable	Hospitals & Clinics Ambulatory Surgery Centres Home Care Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Pressure Monitoring Devices Market, By Product Type:

• Digital Blood Pressure Monitor
• Sphygmomanometer
• Transducers
• Others

• Blood Pressure Monitoring Devices Market, By Technology:

• Digital
• Android
• Wearable

• Blood Pressure Monitoring Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgery Centres
• Home Care
• Others

• Blood Pressure Monitoring Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE